Could boron compounds be effective against SARS-CoV-2?

被引：14

作者：

Ataseven, H. ^{[1
]}

Sayin, K. ^{[2
]}

Tuzun, B. ^{[3
]}

Gedikli, M. A. ^{[4
]}

机构：

[1] Sivas Cumhuriyet Univ, Dept Gastroenterol, Fac Med, Sivas, Turkey

[2] Sivas Cumhuriyet Univ, Fac Sci, Dept Chem, Sivas, Turkey

[3] Sivas Cumhuriyet Univ, Plantal & Anim Prod Dept, Sivas Tech Sci Vocat Sch, Sivas, Turkey

[4] Sivas Cumhuriyet Univ, Fac Med, Dept Internal Med, Sivas, Turkey

来源：

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2021年 / 122卷 / 10期

关键词：

boronate ester; dioxaborole; in silico; SARS-CoV-2; MD calculations; DOCKING; GLIDE;

D O I：

10.4149/BLL_2021_121

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BACKGROUND: Seven dioxaborole compounds are investigated in this study. Structural and spectral characterization is done at M062X/6-31+G(d,p) level in the water. Active sites of these compounds are determined using molecular electrostatic potential (MEP) maps. Electrophilic and nucleophilic attack regions are determined. AIM: We aimed to determine whether Boron-Containing Compounds (BCCs) inhibitor used in the treatment of COVID-19 are effective against SARS Cov-2 in silico. RESULTS AND CONCLUSION: Since SARS-CoV-2 is a worldwide health problem, anti-viral properties of studied boron-containing compounds were investigated by molecular docking calculations. In addition to these calculations, MM/PSBA calculations were performed. It was found that boron compounds can be good drug candidate against SARS-CoV-2 and the best compound is ((R)-1-((S)-3-(4-(aminomethyl)phenyl)-2-benzamidopropanamido)-4-guanidinobutyl)boronic acid (C26).

引用

页码：753 / 758

页数：6

共 35 条

[1] How do arbidol and its analogs inhibit the SARS-CoV-2?
Aktas, A.
Tuzun, B.
Kafa, Taskin A. H.
Sayin, K.
Ataseven, H.
[J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (10): : 705 - 711
[2] Aktas A, AGE, V54, P18
[3] New anti-viral drugs for the treatment of COVID-19 instead of favipiravir
Aktas, Ahmet
Tuzun, Burak
Aslan, Rukiye
Sayin, Koray
Ataseven, Hilmi
[J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (18) : 7263 - 7273
[4] [Anonymous], 2019, RELEASE S 3 MAESTRO
[5] CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]
[6] Could boron-containing compounds (BCCs) be effective against SARS-CoV-2 as anti-viral agent?
Cetiner, E.
Sayin, K.
Tuzun, B.
Ataseven, H.
[J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2021, 122 (04): : 263 - 269
[7] Dennington II R, 2009, GAUSSVIEW 5 0
[8] Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Dong, Liying
Hu, Shasha
Gao, Jianjun
[J]. DRUG DISCOVERIES AND THERAPEUTICS, 2020, 14 (01) : 58 - 60
[9] Current data regarding the structure-toxicity relationship of boron-containing compounds
Farfan-Garcia, E. D.
Castillo-Mendieta, N. T.
Cipres-Floresa, F. J.
Padilla-Martinez, I. I.
Trujillo-Ferrara, J. G.
Soriano-Ursua, M. A.
[J]. TOXICOLOGY LETTERS, 2016, 258 : 115 - 125
[10] Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI [10.46234/ccdcw2020.032, 10.3760/cma.j.issn.0254-6450.2020.02.003]

← 1 2 3 4 →